Citation Impact
Citing Papers
Potent Induction of Tumor Immunity by Combining Tumor Cryoablation with Anti–CTLA-4 Therapy
2011 StandoutNobel
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
2010 Standout
Strategy for Dual-Analyte Luciferin Imaging: In Vivo Bioluminescence Detection of Hydrogen Peroxide and Caspase Activity in a Murine Model of Acute Inflammation
2013 StandoutNobel
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin
2006 StandoutNobel
Prognostic cancer gene signatures share common regulatory motifs
2017
Targeting the tumor vasculature to enhance T cell activity
2015
Targeted glycan degradation potentiates the anticancer immune response in vivo
2020 StandoutNobel
Inference and analysis of cell-cell communication using CellChat
2021 Standout
The Role of Hypoxia in Vascular Injury and Repair
2008
Regulation of microRNA function in animals
2018 Standout
Multiple roles of CD90 in cancer
2016
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Effect of Antisense Hypoxia-inducible Factor 1?? on Progression, Metastasis, and Chemosensitivity of Pancreatic Cancer
2006
Targeting tumor-associated macrophages as a novel strategy against breast cancer
2006
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
2012 Standout
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
A Selenium Analogue of Firefly D ‐Luciferin with Red‐Shifted Bioluminescence Emission
2012 StandoutNobel
Cancer despite immunosurveillance: immunoselection and immunosubversion
2006
Control of human mesothelin-expressing tumors by DNA vaccines
2007
The Fos family of transcription factors and their role in tumourigenesis
2005
Mucosal immunity and vaccines
2005 Standout
Nanoparticle-mediated inhibition of survivin to overcome drug resistance in cancer therapy
2016
Tumor-Associated Macrophages: From Mechanisms to Therapy
2014 Standout
Bacteria as DNA vaccine carriers for genetic immunization
2004
Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake
2006
Thermal ablation of tumours: biological mechanisms and advances in therapy
2014 Standout
Metazoan MicroRNAs
2018 Standout
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
2017 Standout
Biodistribution and function of extracellular miRNA-155 in mice
2015 StandoutNobel
Cancer as an overhealing wound: an old hypothesis revisited
2008 Standout
The properties and applications of nanodiamonds
2011 Standout
The tumour microenvironment as a target for chemoprevention
2007
U1 snRNP regulates cancer cell migration and invasion in vitro
2020 Standout
Oncogenic stress sensed by the immune system: role of natural killer cell receptors
2009
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
2009 Standout
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
2010 Standout
The DNA damage response, immunity and cancer
2006
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Microenvironmental regulation of metastasis
2008 Standout
Macrophage plasticity and polarization: in vivo veritas
2012 Standout
Boosting Bioluminescence Neuroimaging: An Optimized Protocol for Brain Studies
2013
The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells
2008 StandoutNobel
Dendritic cells: Understanding immunogenicity
2007 StandoutNobel
Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions
2011
Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells
2011
Calreticulin exposure dictates the immunogenicity of cancer cell death
2006 Standout
Exploring the full spectrum of macrophage activation
2008 Standout
Association of legumain expression pattern with prostate cancer invasiveness and aggressiveness
2012
Extracellular vesicles: biology and emerging therapeutic opportunities
2013 Standout
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
2011 StandoutNobel
Comparison of red-shifted firefly luciferase Ppy RE9 and conventional Luc2 as bioluminescence imaging reporter genes for <italic>in vivo</italic> imaging of stem cells
2012
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
The Human Cancer Antigen Mesothelin Is More Efficiently Presented to the Mouse Immune System when Targeted to the DEC‐205/CD205 Receptor on Dendritic Cells
2009 StandoutNobel
Trex1 Exonuclease Degrades ssDNA to Prevent Chronic Checkpoint Activation and Autoimmune Disease
2007 StandoutNobel
Enhancing CTL responses to melanoma cell vaccines in vivo: synergistic increases obtained using IFNγ primed and IFNβ treated B7‐1+ B16‐F10 melanoma cells
2003
Stimulation of the Glucocorticoid-Induced TNF Receptor Family-Related Receptor on CD8 T Cells Induces Protective and High-Avidity T Cell Responses to Tumor-Specific Antigens
2010 StandoutNobel
Macrophages define the invasive microenvironment in breast cancer
2008
A Critical Role for Macrophages in Promotion of Urethane-Induced Lung Carcinogenesis
2011
Induction of Postsurgical Tumor Immunity and T-Cell Memory by a Poorly Immunogenic Tumor
2007
The extracellular matrix: A dynamic niche in cancer progression
2012 Standout
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Nanodiamond Therapeutic Delivery Agents Mediate Enhanced Chemoresistant Tumor Treatment
2011
Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanoma
2017
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
Immune Cell Infiltration and Tertiary Lymphoid Structures as Determinants of Antitumor Immunity
2018
In Vivo Bioluminescent Imaging (BLI): Noninvasive Visualization and Interrogation of Biological Processes in Living Animals
2010
Bioorthogonal Labeling of Human Prostate Cancer Tissue Slice Cultures for Glycoproteomics
2017 StandoutNobel
Costimulatory Receptors in a Teleost Fish: Typical CD28, Elusive CTLA4
2006
Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
2014 StandoutNobel
Reversible Low-Light Induced Photoswitching of Crowned Spiropyran-DO3A Complexed with Gadolinium(III) Ions
2012
Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells
2021 StandoutNobel
Emerging Targets in Photopharmacology
2016 StandoutNobel
In Situ Tumor Ablation Creates an Antigen Source for the Generation of Antitumor Immunity
2004
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Gene-based vaccines: recent technical and clinical advances
2006
Phenotypic Characterization of miR-92a−/− Mice Reveals an Important Function of miR-92a in Skeletal Development
2014
Innate or Adaptive Immunity? The Example of Natural Killer Cells
2011 StandoutScience
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Immunogenic Cell Death in Cancer Therapy
2012 Standout
Works of He Zhou being referenced
A Legumain-based minigene vaccine targets the tumor stroma and suppresses breast cancer growth and angiogenesis
2007
MicroRNA-106b promotes colorectal cancer cell migration and invasion by directly targeting DLC1
2015
Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer
2011
A novel DNA vaccine encoding PDGFRβ suppresses growth and dissemination of murine colon, lung and breast carcinoma
2006
FLK-1-based minigene vaccines induce T cell-mediated suppression of angiogenesis and tumor protective immunity in syngeneic BALB/c mice
2006
MicroRNA-92a Functions as an Oncogene in Colorectal Cancer by Targeting PTEN
2013
T-cell receptors in channel catfish: structure and expression of TCR α and β genes
1998
The role of proto-oncogene Fra-1 in remodeling the tumor microenvironment in support of breast tumor cell invasion and progression
2009
Non-Invasive Detection of a Small Number of Bioluminescent Cancer Cells In Vivo
2010
Immunological tumor destruction in a murine melanoma model by targeted LTα independent of secondary lymphoid tissue
2007
Endoglin (CD105) is a target for an oral DNA vaccine against breast cancer
2006
Characterization of stem cell–like cancer cells in immune-competent mice
2006
Development and Analysis of Various Clonal Alloantigen- Dependent Cytotoxic Cell Lines from Channel Catfish
2000
Heterogeneity of Channel Catfish CTL with Respect to Target Recognition and Cytotoxic Mechanisms Employed
2001
Transcription factor Fos-related antigen 1 is an effective target for a breast cancer vaccine
2003
T cell–mediated suppression of angiogenesis results in tumor protective immunity
2005
A DNA Vaccine Targeting Survivin Combines Apoptosis with Suppression of Angiogenesis in Lung Tumor Eradication
2005
DNA-based vaccines activate innate and adaptive antitumor immunity by engaging the NKG2D receptor
2005
A DNA Vaccine Targeting Fos-Related Antigen 1 Enhanced by IL-18 Induces Long-lived T-Cell Memory against Tumor Recurrence
2005